POSTBARIATRIC HYPOGLYCEMIA
Clinical trials for POSTBARIATRIC HYPOGLYCEMIA explained in plain language.
Never miss a new study
Get alerted when new POSTBARIATRIC HYPOGLYCEMIA trials appear
Sign up with your email to follow new studies for POSTBARIATRIC HYPOGLYCEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot aims to stop dangerous sugar crashes after gastric bypass
Disease control CompletedThis study tests a new drug called MBX 1416 in 10 people who have low blood sugar episodes after weight loss surgery. Participants receive two injections of the drug, a low dose and a high dose, about two weeks apart. The goal is to see if the drug can raise the lowest blood suga…
Matched conditions: POSTBARIATRIC HYPOGLYCEMIA
Phase: PHASE2 • Sponsor: MBX Biosciences • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New drug shows promise for Post-Surgery sugar crashes
Disease control CompletedThis study tested a drug called mizagliflozin in 15 people who had gastric bypass surgery and suffer from dangerously low blood sugar after eating. The goal was to see if the drug could reduce these episodes and improve safety. The trial is now complete, and results will help det…
Matched conditions: POSTBARIATRIC HYPOGLYCEMIA
Phase: PHASE2 • Sponsor: Vogenx, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC